Article
Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection.
Applied microbiology and biotechnology - 1 Apr 2020
Kumar Rajesh, Shrivastava Tripti, Samal Sweety, Ahmed Shubbir, Parray Hilal Ahmad
Abstract excerpt
Chikungunya virus (CHIKV), a mosquito-transmitted disease that belongs to the genus Alphaviruses, has been emerged as an epidemic threat over the last two decades, and the recent co-emergence of this virus along with other circulating arboviruses and comorbidities has influenced atypical mortality rate up to 10%. Genetic variation in the virus has resulted in its adaptability towards the new vector Aedes...
Topics
- Aedes
- Animals
- Antibodies, Neutralizing
- Antiviral Agents
- Chikungunya Fever
- Chikungunya virus
- Clinical Trials as Topic
- Genetic Variation
- Humans
- Immunotherapy
- Mosquito Vectors